» Articles » PMID: 38166023

Hypertensive Rats Show Increased Renal Excretion and Decreased Tissue Concentrations of Glycine Betaine, a Protective Osmolyte with Diuretic Properties

Overview
Journal PLoS One
Date 2024 Jan 2
PMID 38166023
Authors
Affiliations
Soon will be listed here.
Abstract

Hypertension leads to water-electrolyte disturbances and end-organ damage. Betaine is an osmolyte protecting cells against electrolyte imbalance and osmotic stress, particularly in the kidneys. This study aimed to evaluate tissue levels and hemodynamic and renal effects of betaine in normotensive and hypertensive rats. Betaine levels were assessed using high-performance liquid chromatography-mass spectrometry (HPLC-MS) in normotensive rats (Wistar-Kyoto, WKYs) and Spontaneously Hypertensive rats (SHRs), a model of genetic hypertension. Acute effects of IV betaine on blood pressure, heart rate, and minute diuresis were evaluated. Gene and protein expression of chosen kidney betaine transporters (SLC6a12 and SLC6a20) were assessed using real-time PCR and Western blot. Compared to normotensive rats, SHRs showed significantly lower concentration of betaine in blood serum, the lungs, liver, and renal medulla. These changes were associated with higher urinary excretion of betaine in SHRs (0.20 ± 0.04 vs. 0.09 ± 0.02 mg/ 24h/ 100g b.w., p = 0.036). In acute experiments, betaine increased diuresis without significantly affecting arterial blood pressure. The diuretic response was greater in SHRs than in WKYs. There were no significant differences in renal expression of betaine transporters between WKYs and SHRs. Increased renal excretion of betaine contributes to decreased concentration of the protective osmolyte in tissues of hypertensive rats. These findings pave the way for studies evaluating a causal relation between depleted betaine and hypertensive organ damage, including kidney injury.

Citing Articles

Exploring the Biomarkers and Potential Mechanisms of Botulinum Toxin Type A in the Treatment of Microglial Inflammatory Activation through P2X7 Receptors based on Transcriptome Sequencing.

Zhang K, Ren Y, Lv J, Mao P, Zhou W, Shi Y Curr Pharm Des. 2024; 30(38):3038-3053.

PMID: 39177140 DOI: 10.2174/0113816128318908240730093036.

References
1.
Sakamoto A, Nishimura Y, Ono H, Sakura N . Betaine and homocysteine concentrations in foods. Pediatr Int. 2002; 44(4):409-13. DOI: 10.1046/j.1442-200x.2002.01591.x. View

2.
Martin J, Finkelstein J . Enzymatic determination of betaine in rat tissues. Anal Biochem. 1981; 111(1):72-6. DOI: 10.1016/0003-2697(81)90230-x. View

3.
Zhou Y, Holmseth S, Hua R, Lehre A, Olofsson A, Poblete-Naredo I . The betaine-GABA transporter (BGT1, slc6a12) is predominantly expressed in the liver and at lower levels in the kidneys and at the brain surface. Am J Physiol Renal Physiol. 2011; 302(3):F316-28. DOI: 10.1152/ajprenal.00464.2011. View

4.
Clow K, Treberg J, Brosnan M, Brosnan J . Elevated tissue betaine contents in developing rats are due to dietary betaine, not to synthesis. J Nutr. 2008; 138(9):1641-6. DOI: 10.1093/jn/138.9.1641. View

5.
Kempson S, Zhou Y, Danbolt N . The betaine/GABA transporter and betaine: roles in brain, kidney, and liver. Front Physiol. 2014; 5:159. PMC: 4006062. DOI: 10.3389/fphys.2014.00159. View